Pharma Tech Outlook: Specials Magazine

For more than four decades, INTERCHEM Corporation has helped companies solve the intricate puzzle of pharmaceutical manufacturing by aligning materials, producers and regulatory expertise. The global contract manufacturing partner serves as a one-stop resource in the custom pharmaceutical space, helping clients bring products to market with speed and precision. Backed by a worldwide network of trusted partners and a track record of navigating complex regulations, Interchem gives clients the confidence and agility to compete in dynamic markets. Its broad portfolio of chemistries and deep in-house technical and regulatory expertise efficiently delivers tailored solutions. Whether it's product selection, new-product development or custom logistics, Interchem’s experienced team fulfills every need. The team includes industry veterans who have tackled virtually every type of development challenge. Many have been with the company for over 15 years. “Our advantage is that we can leverage our broad areas of expertise to assist our clients in getting products to market faster,” says Bob Golle, vice president. “We are nimble and operate quickly because we perform all services in-house.” This integrated model is strengthened by its role as a sales and marketing representative and regulatory agent for a vast network of CMOs across different regions. Clients get access to a wide-reaching, well-coordinated manufacturing ecosystem. Interchem’s wealth of capabilities, applied globally, accommodates an array of project requirements, including production scale, technologies, quality and regulatory requirements and timelines. The focus is always on matching the client’s requirements with the manufacturer most capable of delivering them. This guarantees faster turnaround and fewer headaches. Interchem also specializes in antibiotic production, custom manufacturing services and patent assessments. Its long-term partnership with ACS Dobfar has enabled it to develop an expansive collection of cephalosporins, penicillins, carbapenems and other anti-infectives, in lyophilized, injectable and bag form, to U.S. and international pharmaceutical companies. It also owns and markets a veterinary brand, U.S. Vet. For patent assessments, it combines the expertise of its in-house team and outside counsel with whom Interchem has worked for decades. To facilitate the process, its newly formed product selection team leverages extensive market knowledge and accesses numerous highly respected market research databases and services.

Exouza offers OpenPBM.ai, a next-generation pharmacy management administrative platform that empowers employers to better manage rising costs and navigate the complexities of the healthcare ecosystem. By combining intelligent technology, white-glove service and radical flexibility, it drives tangible financial savings, stronger employee engagement and a healthcare experience aligned with current expectations. This forward-thinking solution comes at a critical time. Pharmacy costs are now one of the largest drivers of healthcare spending, and can account for 25 percent of an employer’s total costs. Despite this, traditional pharmacy benefit managers (PBM) continue to rely on outdated, rigid, and opaque models that offer limited transparency, minimal control and little influence on outcomes. Compounding the issue is the high cost of specialty drugs. Although used by only about three percent of the population, the high price of these medications means they account for over half of total drug spending. Much of the complexity and inefficiency surrounding drug pricing is the widely used practice of negotiated rates between PBMs and pharmacies. But this practice does not provide real-time, market-based pricing across a variety of prescription drug suppliers. OpenPBM.ai is the first PBM platform that “shops” for the best price for prescription drugs from multiple sources, not just a contracted rate with a pharmacy, delivering unmatched value to both employers and employees. “Nearly every other industry allows shopping for prices with fully transparency to buyers. Now for the first time, Exouza brings this experience to prescription drug pricing and management. We saw the growing gap and approached it with a blank canvas,” says Susheel Jain, CEO. Rather than adapting outdated systems OpenPBM.ai was built from scratch as a modern, agile, and data-driven PBM platform. Its intuitive app and portal—covering administration, finance, access, clinical management and customer service—are designed with an open architecture to integrate best-in-class capabilities, giving customers the flexibility and customization they need now and in the future. Integration and interoperability with vetted partners and third party systems enables smooth data flow and real-time tracking of member and drug status at every stage. If an issue arises with one partner, OpenPBM.ai immediately identifies the next best route and guides the member to an alternative program or solution, ensuring continuity and support..